Importance of asymmetrical dimethylarginine in cardiovascular risk.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to P Vallance.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
In animals and humans, inhibition of nitric oxide (NO) production has widespread effects. Reduced activity of the NO:cyclic GMP pathway has been documented in disease states, including hypertension, diabetes and certain types of renal disease. Inhibitors of NO synthesis occur endogenously, and have been implicated in the regulation of the NO pathway in health and disease. Here we review the possible biological roles of endogenous NO synthase inhibitors, with particular reference to renal disease.
Nitric oxide is involved in a wide range of physiological processes in humans and in animals. It controls vascular tone, acts as a neurotransmitter and neuromodulator in the central and peripheral nervous systems and influences the activity of the immune system. Substances that selectively enhance or inhibit its synthesis or removal and modify its effects, are likely to yield interesting therapeutic agents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.